News & Updates
Filter by Specialty:
Use of alternative medicine not uncommon in melanoma patients
About one in four cutaneous melanoma patients use at least one type of complementary and alternative medicine (CAM), of which herbs and turmeric are the most popular, reveals a prospective study from a tertiary cancer centre in Turkey.
Use of alternative medicine not uncommon in melanoma patients
09 Mar 2022
Point-of-care diagnostics feasible for COVID-19 border testing
Point-of-care (POC) diagnostic methods, such as serology or nucleic acid amplification (NAAT) tests, have high specificity and sensitivity for the coronavirus disease 2019 (COVID-19) and can be effectively deployed as border control mechanisms, according to a recent Singapore study.
Point-of-care diagnostics feasible for COVID-19 border testing
09 Mar 2022
Female sex, hypertension, number of initial symptoms tied to long COVID risk
The risk of developing long COVID is high among women, hypertensives, and those with a higher number of initial symptoms, and these associations are independent of disease severity and clinical course, a study has found.
Female sex, hypertension, number of initial symptoms tied to long COVID risk
09 Mar 2022
Whole-exome sequencing enhances diagnosis in young CRC patients
Whole-exome sequencing (WES) can improve diagnosis rates in young colorectal cancer (CRC) patients who show no pathogenic variants in mismatch repair (MMR) genes or in the adenomatous polyposis coli (APC) gene, reports a recent study.
Whole-exome sequencing enhances diagnosis in young CRC patients
09 Mar 2022
Post-COVID sequelae conditions identified, could help establish definition
Patients diagnosed with COVID-19 could have an increased risk of certain conditions up to 120 days post-diagnosis, a finding which could help establish the definition of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), according to a study presented at CROI 2022.
Post-COVID sequelae conditions identified, could help establish definition
08 Mar 2022
Neoplastic progression to pancreatic cancer slips by imaging surveillance
Imaging-based surveillance techniques may miss hallmarks of progression in high-risk individuals presenting with high-grade dysplasia or pancreatic cancer, suggesting a need for more sensitive tools, a recent study has found.
Neoplastic progression to pancreatic cancer slips by imaging surveillance
08 Mar 2022
Immune-related adverse events portend better prognosis in ICI-treated hepatocellular carcinoma
Among advanced hepatocellular carcinoma patients being treated with immune checkpoint inhibitors (ICIs), the occurrence of multisystem and more severe immune-related adverse events is a favourable signal, being associated with survival advantage, according to a Singapore study.
